ArticlePLoS biology2018

CRISPR/Cas9 gene editing for the creation of an MGAT1-deficient CHO cell line to control HIV-1 vaccine glycosylation.

Gabriel Byrne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.